Astera Labs, Inc. (NASDAQ:ALAB) Receives Average Recommendation of “Moderate Buy” from Analysts

Astera Labs, Inc. (NASDAQ:ALAB) has earned an average rating of “Moderate Buy” from the twenty-one analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $192.8889.

A number of brokerages recently issued reports on ALAB. Barclays set a $165.00 target price on shares of Astera Labs in a research report on Thursday, January 15th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Stifel Nicolaus increased their price target on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. raised their price target on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th.

Insider Buying and Selling

In other news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the sale, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This trade represents a 8.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, General Counsel Philip Mazzara sold 4,849 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.80, for a total transaction of $600,306.20. Following the transaction, the general counsel owned 138,084 shares in the company, valued at approximately $17,094,799.20. This trade represents a 3.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 389,792 shares of company stock valued at $56,013,809 in the last 90 days. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

A number of large investors have recently modified their holdings of ALAB. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Astera Labs by 21.6% in the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after acquiring an additional 2,624 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Astera Labs by 94.6% in the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after purchasing an additional 53,276 shares during the period. Harbour Investments Inc. increased its stake in Astera Labs by 207.7% during the 2nd quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock worth $221,000 after purchasing an additional 1,651 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Astera Labs by 34.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock worth $47,208,000 after purchasing an additional 133,961 shares in the last quarter. Finally, Corient Private Wealth LLC bought a new stake in Astera Labs during the 2nd quarter worth approximately $543,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Price Performance

Astera Labs stock opened at $128.15 on Thursday. The business has a 50 day simple moving average of $159.52 and a 200 day simple moving average of $173.36. The company has a market capitalization of $21.81 billion, a PE ratio of 105.04, a price-to-earnings-growth ratio of 2.53 and a beta of 1.50. Astera Labs has a one year low of $47.13 and a one year high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business’s revenue was up 91.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts anticipate that Astera Labs will post 0.34 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.